Insider · CIK 0001708172
James R. Kasinger
officer
Files at CRSP (CRISPR Therapeutics AG). First filing Oct 15, 2024, latest Oct 8, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $1.7M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRSP: CRISPR Therapeutics AG
CRSPOct 9, 2026 · close 53.39
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | CRISPR Therapeutics AG | $119k 1,990 shares | -2% | +22% from low-30% from high | |
| 8Weak | CRISPR Therapeutics AG | $626k 10,400 shares | -10% | +33% from low-23% from high | |
| 26Weak | CRISPR Therapeutics AG | $131k 3,185 shares | -4% | - | |
| 26Weak | CRISPR Therapeutics AG | $169k 3,966 shares | -5% | - | |
| 40Moderate | CRISPR Therapeutics AG | $619k 11,542 shares | -14% | - | |
| 15Weak | CRISPR Therapeutics AG | $50k 1,089 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares10b5-1 | +1,990 | $13.62 | $27k | 96,774 | 4 d ago |
| Oct 6, 2026 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares10b5-1 | -1,990 | $60.04 | $119k | 94,784 | 4 d ago |
| Oct 6, 2026 | CRSP CRISPR Therapeutics AG | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,990 | $0.00 | $0 | 81,242 | 4 d ago |
| Sep 22, 2026 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares10b5-1 | +10,400 | $13.62 | $142k | 105,184 | 18 d ago |
| Sep 22, 2026 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares10b5-1 | -10,400 | $60.24 | $626k | 94,784 | 18 d ago |
| Sep 22, 2026 | CRSP CRISPR Therapeutics AG | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,400 | $0.00 | $0 | 83,232 | 18 d ago |
| Mar 20, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +6,250 | - | - | 84,914 | Mar 24, 2025 |
| Mar 21, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -3,185 | $41.23 | $131k | 81,729 | Mar 24, 2025 |
| Mar 20, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -6,250 | - | - | 18,750 | Mar 24, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +36,666 | $0.00 | $0 | 36,666 | Mar 18, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Restricted Stock Unitsderivative | +27,500 | $0.00 | $0 | 27,500 | Mar 18, 2025 |
| Mar 10, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +5,500 | - | - | 80,380 | Mar 12, 2025 |
| Mar 11, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -2,850 | $42.42 | $121k | 77,530 | Mar 12, 2025 |
| Mar 11, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +2,250 | - | - | 79,780 | Mar 12, 2025 |
| Mar 12, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -1,116 | $43.32 | $48k | 78,664 | Mar 12, 2025 |
| Mar 10, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -5,500 | - | - | 11,000 | Mar 12, 2025 |
| Mar 11, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -2,250 | - | - | 0 | Mar 12, 2025 |
| Feb 16, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +20,000 | - | - | 82,597 | Feb 19, 2025 |
| Feb 18, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -9,595 | $53.85 | $517k | 73,002 | Feb 19, 2025 |
| Feb 18, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +3,825 | - | - | 76,827 | Feb 19, 2025 |
| Feb 19, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -1,947 | $52.80 | $103k | 74,880 | Feb 19, 2025 |
| Feb 16, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -20,000 | - | - | 0 | Feb 19, 2025 |
| Feb 18, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -3,825 | - | - | 3,825 | Feb 19, 2025 |
| Oct 16, 2024 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +18,333 | $0.00 | $0 | 18,333 | Oct 18, 2024 |
| Oct 16, 2024 | CRSP CRISPR Therapeutics AG | AGrant or award Restricted Stock Unitsderivative | +30,000 | $0.00 | $0 | 30,000 | Oct 18, 2024 |
| Oct 13, 2024 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +2,113 | - | - | 63,686 | Oct 15, 2024 |
| Oct 14, 2024 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -1,089 | $46.28 | $50k | 62,597 | Oct 15, 2024 |
| Oct 13, 2024 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -2,113 | - | - | 4,227 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.